What's New

eCOMMUNITY RETIRING IN JUNE

Please be advised that the BPS e-Community section of the website will be retired by the end of June 2014.

The Society is doing all it can to deliver its strategic objective to ‘greater match the Society’s activities to the needs of its membership’. The Your BPS member engagement survey highlighted that the e-Community was not highly valued by members in comparison with the main website.

From June 2014, the Members’ Area of the website will become your access point for all online member services offered by BPS. Any information that you have shared previously through the e-Community will be stored securely offline as part of the Society’s archive and in keeping with our existing policies.

 

Do you want to help us modernize our website?
The Society is keen to engage a small group of members in developing future improvements to the website. If you would like to register your interest in participating in testing updates, please contact info@bps.ac.uk with the subject line ‘Volunteer for website testing’.

In the Know

LATEST PHARMACOLOGY NEWS

Mode of action of new multiple sclerosis drug discovered

- (idw) Universität zu Lübeck Dimethyl fumarate inhibits inflammatory cell infiltration of the central nervous system through blockade of a specific receptor Just a few short weeks ago, dimethyl fumarate was approved in Europe as a basic therapy for multiple sclerosis.

New paracetamol overdose treatment costs millions but doesn’t save many lives

Strict guidelines that were introduced 18 months ago following the death of a young

Call for review on overdose treatment

The NHS needs to review its costly treatment of paracetamol overdoses which could be putting some patients at

Recreational drug users who switch from ecstasy to mephedrone don't understand the dangers

Contrary to popular belief among recreational drug users,

View More Recent News

Our Community

ANNOUNCEMENTS

Advocates of gender-balanced research tell Tania Rabesandratana how EU policymakers could do more to

Interview with Fiona Marshall cofounder and Chief Scientific officer of Heptares Therapeutics Ltd

For women in work this is a perfect storm of inequality

FOLLOW US ON

 Find Us on Facebook    Follow Us on Twitter